1. Home
  2. Detail

@bichtruong546:

Tupi- ❤️❤️
Tupi- ❤️❤️
Open In TikTok:
Region: US
Saturday 07 November 2026 14:42:04 GMT
128
3
0
0

Music

Download

No Watermark .mp4 (0MB) Watermark .mp4 (0MB) Music .mp3

Comments

There are no more comments for this video.
To see more videos from user @bichtruong546, please go to the Tikwm homepage.

Other Videos

yea.. what you over here bein messy for tiktok? #messytiktok #keairis
yea.. what you over here bein messy for tiktok? #messytiktok #keairis
Clinical research can be a maze, especially when it comes to reporting deviations. Sponsors often prefer minimizing unnecessary reports to the IRB, yet keeping compliance tight is crucial. Always double-check specific reporting requirements for each study, and if you’re unsure, reach out—even if getting a human on the phone feels impossible. Navigating these relationships is an art form! #clinicalresearch #clinicaltrials #irb #cra #researchcoordinator
Clinical research can be a maze, especially when it comes to reporting deviations. Sponsors often prefer minimizing unnecessary reports to the IRB, yet keeping compliance tight is crucial. Always double-check specific reporting requirements for each study, and if you’re unsure, reach out—even if getting a human on the phone feels impossible. Navigating these relationships is an art form! #clinicalresearch #clinicaltrials #irb #cra #researchcoordinator
PAY ME!😂 #keairis
PAY ME!😂 #keairis
Korean Haircare is in 2050?!🫨 #moev #koreanhaircare #haircare #sylekorean #stylekorean_global #silkyhair #hairstyle #longhair #koreanhaircare #koreanbeauty #kbeauty
Korean Haircare is in 2050?!🫨 #moev #koreanhaircare #haircare #sylekorean #stylekorean_global #silkyhair #hairstyle #longhair #koreanhaircare #koreanbeauty #kbeauty


Is the golden age of CROs coming to an end? Big Pharma is starting to question the outsourcing model, especially with ongoing frustrations over site payments and operational bottlenecks. When handling it in-house becomes more economically advantageous and efficient, the shift away from outsourcing seems inevitable. It’s a massive pivot in the industry worth watching. #biotech #bigpharma #clinicaltrials #cro #pharmaceuticals
Is the golden age of CROs coming to an end? Big Pharma is starting to question the outsourcing model, especially with ongoing frustrations over site payments and operational bottlenecks. When handling it in-house becomes more economically advantageous and efficient, the shift away from outsourcing seems inevitable. It’s a massive pivot in the industry worth watching. #biotech #bigpharma #clinicaltrials #cro #pharmaceuticals

About

Legal